ESR1 and cancer: Worthy, it has been also demonstrated that upon activation by ligands, including 3MC, AHR triggers stimulatory effects in cancer cells through a functional cooperation with the estrogen receptor α (ERα) and other transduction pathways as growth factor receptors [24–30].